home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.1002 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 16, 2024

Via Benzinga

Applied Therapeutics Added to Russell 3000® Index

July 01, 2024

From Applied Therapeutics

Via GlobeNewswire

Top 4 Health Care Stocks That May Keep You Up At Night This Month ↗

June 11, 2024

Via Benzinga

APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

APLT stock results show that Applied Therapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Applied Therapeutics Reports First Quarter 2024 Financial Results

May 09, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics: Q4 Earnings Insights ↗

March 06, 2024

Via Benzinga

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

May 07, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

April 15, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

April 04, 2024

From Applied Therapeutics

Via GlobeNewswire

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease ↗

April 01, 2024

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates...

Via Benzinga

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗

April 01, 2024

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 01, 2024

Via Benzinga

Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 01, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 29, 2024

Via Benzinga

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

March 28, 2024

From Applied Therapeutics

Via GlobeNewswire

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday ↗

March 11, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Via Benzinga

Topics Stocks

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

March 06, 2024

From Applied Therapeutics

Via GlobeNewswire

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday ↗

February 28, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.

Via Benzinga

Topics Stocks

FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder ↗

February 28, 2024

Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it would be the first medication for Galactosemia. APLT also submits MAA to...

Via Benzinga

Why Is Coupang (CPNG) Stock Up 4% Today? ↗

February 28, 2024

Coupang stock is rallying on Wednesday as investors in CPNG celebrate the company beating out EPS and revenue estimates for Q4.

Via InvestorPlace

Applied Therapeutics Inc. (NASDAQ: APLT) Records 52-Week High Wednesday Morning

February 28, 2024

Via Investor Brand Network

Why Is Applied Therapeutics (APLT) Stock Up 59% Today? ↗

February 28, 2024

Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.

Via InvestorPlace

Applied Therapeutics Announces $100 Million Private Placement

February 28, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

February 28, 2024

From Applied Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 16, 2024

Via Benzinga

Why Is Rare Disease-Focused Applied Therapeutics Stock Trading Higher Today? ↗

February 15, 2024

Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD Deficiency...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 15, 2024

Via Benzinga

Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

February 15, 2024

From Applied Therapeutics

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com